{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,30]],"date-time":"2026-04-30T08:49:15Z","timestamp":1777538955353,"version":"3.51.4"},"reference-count":35,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2011,8,1]],"date-time":"2011-08-01T00:00:00Z","timestamp":1312156800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2011,8,1]],"date-time":"2011-08-01T00:00:00Z","timestamp":1312156800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2011,8,1]],"date-time":"2011-08-01T00:00:00Z","timestamp":1312156800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2011,8,1]],"date-time":"2011-08-01T00:00:00Z","timestamp":1312156800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2011,8,1]],"date-time":"2011-08-01T00:00:00Z","timestamp":1312156800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2011,8,1]],"date-time":"2011-08-01T00:00:00Z","timestamp":1312156800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2011,8,1]],"date-time":"2011-08-01T00:00:00Z","timestamp":1312156800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100007308","name":"Sveriges L\u00e4karf\u00f6rbund","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100007308","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100010771","name":"Loo och Hans Ostermans Stiftelse f\u00f6r Medicinsk Forskning","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100010771","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004047","name":"Karolinska Institutet","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004047","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004359","name":"Vetenskapsr\u00e5det","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004359","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Experimental Neurology"],"published-print":{"date-parts":[[2011,8]]},"DOI":"10.1016\/j.expneurol.2011.04.016","type":"journal-article","created":{"date-parts":[[2011,5,2]],"date-time":"2011-05-02T02:06:20Z","timestamp":1304301980000},"page":"197-206","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":8,"title":["APOE \u03b53 attenuates experimental autoimmune neuritis by modulating T cell, macrophage and Schwann cell functions"],"prefix":"10.1016","volume":"230","author":[{"given":"Hong-Liang","family":"Zhang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xi-Jing","family":"Mao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xing-Mei","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hai-Feng","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiang-Yu","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Abdu","family":"Adem","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eilhard","family":"Mix","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jie","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.expneurol.2011.04.016_bb0005","doi-asserted-by":"crossref","first-page":"922","DOI":"10.1161\/01.RES.0000187467.67684.43","article-title":"Apolipoprotein E suppresses the type I inflammatory response in vivo","volume":"97","author":"Ali","year":"2005","journal-title":"Circ. Res."},{"key":"10.1016\/j.expneurol.2011.04.016_bb0010","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1124\/pr.55.2.4","article-title":"Interleukin-10 therapy \u2014 review of a new approach","volume":"55","author":"Asadullah","year":"2003","journal-title":"Pharmacol. Rev."},{"key":"10.1016\/j.expneurol.2011.04.016_bb0015","doi-asserted-by":"crossref","first-page":"93","DOI":"10.2174\/1568006013337944","article-title":"Apolipoprotein E: possible therapeutic target for atherosclerosis","volume":"1","author":"Bocksch","year":"2001","journal-title":"Curr. Drug Targets Cardiovasc. Haematol. Disord."},{"key":"10.1016\/j.expneurol.2011.04.016_bb0020","series-title":"Fmoc Solid Phase Peptide Synthesis: A Practical Approach","author":"Chan","year":"2000"},{"key":"10.1016\/j.expneurol.2011.04.016_bb0025","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1016\/S0197-4580(02)00016-7","article-title":"APOE and the regulation of microglial nitric oxide production: a link between genetic risk and oxidative stress","volume":"23","author":"Colton","year":"2002","journal-title":"Neurobiol. Aging"},{"key":"10.1016\/j.expneurol.2011.04.016_bb0030","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1016\/j.expneurol.2004.01.026","article-title":"Inducible nitric oxide synthase (iNOS) in immune-mediated demyelination and Wallerian degeneration of the rat peripheral nervous system","volume":"187","author":"Conti","year":"2004","journal-title":"Exp. Neurol."},{"key":"10.1016\/j.expneurol.2011.04.016_bb0035","doi-asserted-by":"crossref","first-page":"772","DOI":"10.1002\/glia.20498","article-title":"Apolipoprotein E deficiency enhances the antigen-presenting capacity of Schwann cells","volume":"55","author":"Duan","year":"2007","journal-title":"Glia"},{"key":"10.1016\/j.expneurol.2011.04.016_bb0040","doi-asserted-by":"crossref","first-page":"628","DOI":"10.1515\/CCLM.2003.094","article-title":"The common polymorphism of apolipoprotein E. Geographical aspects and new pathophysiological relations","volume":"41","author":"Gerdes","year":"2003","journal-title":"Clin. Chem. Lab. Med."},{"key":"10.1016\/j.expneurol.2011.04.016_bb0045","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1002\/gepi.1370090302","article-title":"Apolipoprotein E polymorphism in a Danish population compared to findings in 45 other study populations around the world","volume":"9","author":"Gerdes","year":"1992","journal-title":"Genet. Epidemiol."},{"key":"10.1016\/j.expneurol.2011.04.016_bb0050","doi-asserted-by":"crossref","first-page":"s156","DOI":"10.1194\/jlr.R800058-JLR200","article-title":"Apoprotein E as a lipid transport and signaling protein in the blood, liver, and artery wall","volume":"50","author":"Getz","year":"2009","journal-title":"J. Lipid Res."},{"key":"10.1016\/j.expneurol.2011.04.016_bb0055","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1111\/j.1750-3639.1999.tb00231.x","article-title":"Mechanisms of immune regulation in the peripheral nervous system","volume":"9","author":"Gold","year":"1999","journal-title":"Brain Pathol."},{"key":"10.1016\/j.expneurol.2011.04.016_bb0060","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1016\/S0140-6736(97)12308-X","article-title":"Guillain\u2013Barr\u00e9 syndrome","volume":"352","author":"Hahn","year":"1998","journal-title":"Lancet"},{"key":"10.1016\/j.expneurol.2011.04.016_bb0065","doi-asserted-by":"crossref","first-page":"1653","DOI":"10.1016\/S0140-6736(05)67665-9","article-title":"Guillain\u2013Barr\u00e9 syndrome","volume":"366","author":"Hughes","year":"2005","journal-title":"Lancet"},{"key":"10.1016\/j.expneurol.2011.04.016_bb0070","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1006\/cimm.1994.1302","article-title":"Apolipoprotein E inhibition of proliferation of mitogen-activated T lymphocytes: production of interleukin 2 with reduced biological activity","volume":"159","author":"Kelly","year":"1994","journal-title":"Cell. Immunol."},{"key":"10.1016\/j.expneurol.2011.04.016_bb0075","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1016\/j.neuron.2009.06.026","article-title":"The role of apolipoprotein E in Alzheimer's disease","volume":"63","author":"Kim","year":"2009","journal-title":"Neuron"},{"issue":"Suppl 2","key":"10.1016\/j.expneurol.2011.04.016_bb0080","doi-asserted-by":"crossref","first-page":"S169","DOI":"10.1086\/513795","article-title":"Mechanisms of Schwann cell damage in inflammatory neuropathy","volume":"176","author":"Koski","year":"1997","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.expneurol.2011.04.016_bb0085","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1016\/S0022-2275(20)32409-3","article-title":"Altered immune responses in apolipoprotein E-deficient mice","volume":"41","author":"Laskowitz","year":"2000","journal-title":"J. Lipid Res."},{"key":"10.1016\/j.expneurol.2011.04.016_bb0090","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1161\/01.CIR.104.2.197","article-title":"In vivo downregulation of T helper cell 1 immune responses reduces atherogenesis in apolipoprotein E-knockout mice","volume":"104","author":"Laurat","year":"2001","journal-title":"Circulation"},{"key":"10.1016\/j.expneurol.2011.04.016_bb0095","doi-asserted-by":"crossref","first-page":"1871","DOI":"10.1016\/j.febslet.2008.04.056","article-title":"The involvement of caspase-11 in TPEN-induced apoptosis","volume":"582","author":"Lee","year":"2008","journal-title":"FEBS Lett."},{"key":"10.1016\/j.expneurol.2011.04.016_bb0100","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1096\/fj.05-5423fje","article-title":"Neurotoxicity from innate immune response is greatest with targeted replacement of E4 allele of apolipoprotein E gene and is mediated by microglial p38MAPK","volume":"20","author":"Maezawa","year":"2006","journal-title":"FASEB"},{"key":"10.1016\/j.expneurol.2011.04.016_bb0105","doi-asserted-by":"crossref","first-page":"622","DOI":"10.1126\/science.3283935","article-title":"Apolipoprotein E: cholesterol transport protein with expanding role in cell biology","volume":"240","author":"Mahley","year":"1988","journal-title":"Science"},{"key":"10.1016\/j.expneurol.2011.04.016_bb0110","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.neulet.2009.12.045","article-title":"TNF-alpha receptor 1 deficiency reduces antigen-presenting capacity of Schwann cells and ameliorates experimental autoimmune neuritis in mice","volume":"470","author":"Mao","year":"2010","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.expneurol.2011.04.016_bb0115","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1002\/mus.20893","article-title":"The immunocompetence of Schwann cells","volume":"37","author":"Meyer zu H\u00f6rste","year":"2008","journal-title":"Muscle Nerve"},{"key":"10.1016\/j.expneurol.2011.04.016_bb0120","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1172\/JCI1124","article-title":"Cholesterol lowering in low density lipoprotein receptor knockout mice overexpressing apolipoprotein E","volume":"102","author":"Osuga","year":"1998","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.expneurol.2011.04.016_bb0125","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1212\/WNL.58.3.476","article-title":"Non-T(H)1 cytokines are augmented systematically early in Guillain\u2013Barr\u00e9 syndrome","volume":"58","author":"Press","year":"2002","journal-title":"Neurology"},{"key":"10.1016\/j.expneurol.2011.04.016_bb0130","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1136\/jnnp.74.7.971","article-title":"Apolipoprotein E genotypes and clinical outcome in Guillain\u2013Barr\u00e9 syndrome","volume":"74","author":"Pritchard","year":"2003","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"10.1016\/j.expneurol.2011.04.016_bb0135","doi-asserted-by":"crossref","first-page":"4171","DOI":"10.1016\/S0021-9258(18)34702-1","article-title":"Human apolipoprotein E. The complete amino acid sequence","volume":"257","author":"Rall","year":"1982","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.expneurol.2011.04.016_bb0140","doi-asserted-by":"crossref","first-page":"11445","DOI":"10.1523\/JNEUROSCI.1972-08.2008","article-title":"Impact of apolipoprotein E (ApoE) polymorphism on brain ApoE levels","volume":"28","author":"Riddell","year":"2008","journal-title":"J. Neurosci."},{"key":"10.1016\/j.expneurol.2011.04.016_bb0145","doi-asserted-by":"crossref","first-page":"3261","DOI":"10.1523\/JNEUROSCI.18-09-03261.1998","article-title":"Glial fibrillary acidic protein-apolipoprotein E (apoE) transgenic mice: astrocyte-specific expression and differing biological effects of astrocyte-secreted apoE3 and apoE4 lipoproteins","volume":"18","author":"Sun","year":"1998","journal-title":"J. Neurosci."},{"key":"10.1016\/j.expneurol.2011.04.016_bb0150","doi-asserted-by":"crossref","first-page":"1350","DOI":"10.1016\/j.neurobiolaging.2007.11.014","article-title":"APOE genotype-specific differences in the innate immune response","volume":"30","author":"Vitek","year":"2009","journal-title":"Neurobiol. Aging"},{"key":"10.1016\/j.expneurol.2011.04.016_bb0155","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1084\/jem.102.2.213","article-title":"Allergic neuritis: an experimental disease of rabbits induced by the injection of peripheral nervous tissue and adjuvants","volume":"102","author":"Waksman","year":"1955","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.expneurol.2011.04.016_bb0160","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1093\/jnen\/63.2.120","article-title":"Increased susceptibility to experimental autoimmune neuritis after upregulation of the autoreactive T cell response to peripheral myelin antigen in apolipoprotein E-deficient mice","volume":"63","author":"Yu","year":"2004","journal-title":"J. Neuropathol. Exp. Neurol."},{"key":"10.1016\/j.expneurol.2011.04.016_bb0165","doi-asserted-by":"crossref","first-page":"357412","DOI":"10.1155\/2010\/357412","article-title":"The role of apolipoprotein E in Guillain\u2013Barr\u00e9 syndrome and experimental autoimmune neuritis","volume":"2010","author":"Zhang","year":"2010","journal-title":"J. Biomed. Biotechnol."},{"key":"10.1016\/j.expneurol.2011.04.016_bb0170","first-page":"186813","article-title":"The immune-modulatory role of apolipoprotein E with emphasis on multiple sclerosis and experimental autoimmune encephalomyelitis","volume":"2010","author":"Zhang","year":"2010","journal-title":"Clin. Dev. Immunol."},{"key":"10.1016\/j.expneurol.2011.04.016_bb0175","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1006\/clin.1997.4356","article-title":"Cytokine dichotomy in peripheral nervous system influences the outcome of experimental allergic neuritis: dynamics of mRNA expression for IL-1 beta, IL-6, IL-10, IL12, TNF-alpha, TNF-beta and cytolysin","volume":"84","author":"Zhu","year":"1997","journal-title":"Clin. Immunol. Immunopathol."}],"container-title":["Experimental Neurology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014488611001476?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014488611001476?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,3]],"date-time":"2025-11-03T05:45:39Z","timestamp":1762148739000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0014488611001476"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,8]]},"references-count":35,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2011,8]]}},"alternative-id":["S0014488611001476"],"URL":"https:\/\/doi.org\/10.1016\/j.expneurol.2011.04.016","relation":{},"ISSN":["0014-4886"],"issn-type":[{"value":"0014-4886","type":"print"}],"subject":[],"published":{"date-parts":[[2011,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"APOE \u03b53 attenuates experimental autoimmune neuritis by modulating T cell, macrophage and Schwann cell functions","name":"articletitle","label":"Article Title"},{"value":"Experimental Neurology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.expneurol.2011.04.016","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2011 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}